Estimation of Intangible Costs for Factors Associated with Oral Antiviral Drugs for COVID-19 Treatment: A Conjoint Analysis in Japan-Reference-Cited by-同舟云学术

Estimation of Intangible Costs for Factors Associated with Oral Antiviral Drugs for COVID-19 Treatment: A Conjoint Analysis in Japan

Published:2023-06-12 Issue:8 Volume:40 Page:3525-3542
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Hosogaya Naoki^ORCID,Takazono Takahiro^ORCID,Kurazono Kenji^ORCID,Hiroi Shinzo^ORCID,Iwasaki Kosuke,Takeshima Tomomi^ORCID,Ha Chise,Mukae Hiroshi^ORCID

Funder

Shionogi

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12325-023-02564-4.pdf

Reference24 articles.

1. Hosogaya N, Takazono T, Yokomasu A, et al. Estimation of the value of convenience in taking influenza antivirals in Japanese adult patients between baloxavir marboxil and neuraminidase inhibitors using a conjoint analysis. J Med Econ. 2021;24:244–54.

2. Kurazono K, Ikeoka H, Hiroi S, et al. Comparison of inconvenience costs between influenza antivirals for japanese pediatric patients: a conjoint analysis of parental responses. Adv Ther. 2022;39:1724–42.

3. Bridges JF, Hauber AB, Marshall D, et al. Conjoint analysis applications in health—a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health. 2011;14:403–13.

4. Kawata K, Nakabayashi M. Determinants of COVID-19 vaccine preference: a survey study in Japan. SSM Popul Health. 2021;15: 100902.

5. Igarashi A, Nakano Y, Yoneyama-Hirozane M. Public preferences and willingness to accept a hypothetical vaccine to prevent a pandemic in Japan: a conjoint analysis. Expert Rev Vaccines. 2022;21:241–8.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Updated beliefs and shaken confidence: evidence from vaccine hesitancy caused by experiencing “COVID arm”;BMC Infectious Diseases;2023-09-18